Neurotech shares jump 25% as chairman speaks of ‘considerable opportunity’ by Steve Jones August 27, 2026August 27, 2026 Shares in drug development firm Neurotech International opened 25% higher today as it spruiked its progress […]
Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial by Adam Sheldon March 25, 2026March 26, 2026
